News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEvents
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Cancer Support Community.

Advertisement

Articles by Cancer Support Community.

Biden Cancer Initiative Names Cancer Support Community CEO Kim Thiboldeaux to Board of Directors

ByCancer Support Community.
June 27th 2017

The Biden Cancer Initiative has named Kim Thiboldeaux, the CEO of Cancer Support Community, to its Board of Directors.

Advertisement

Latest Updated Articles

  • Biden Cancer Initiative Names Cancer Support Community CEO Kim Thiboldeaux to Board of Directors
    Biden Cancer Initiative Names Cancer Support Community CEO Kim Thiboldeaux to Board of Directors

    Published: June 27th 2017 | Updated:



Advertisement
Advertisement

Trending on Oncology Nursing News

1

A Note From the Editors on Alex Pretti’s Passing

2

ROSELLA Trial Meets OS End Point and More Ovarian Cancer News

3

Gedatolisib Given FDA Priority Review and More Breast Cancer News

4

Sub-Q Daratumumab/VRd Wins Approval in Newly Diagnosed Multiple Myeloma

5

FDA OKs Nelarabine Larger Vial Size for T-ALL and T-LBL: Data and Dosing

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us